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Cytotoxicity of weak electrolytes after the adaptation of
cells to low pH: role of the transmembrane pH gradient
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Summary Theory suggests that the transmembrane pH gradient may be a major determinant ofthe distribution oflipophilic weak electrolytes
across the cell membrane. The present study evaluates the extent to which this factor contributes to pH-dependentchanges in the cytotoxicity
of two such chemotherapeutic drugs: chlorambucil and mitoxantrone. Experiments were performed with two cell types of the same origin but
exhibiting different pH gradients at the same extracellular pH (pHe): CHO cells cultured under normal physiological conditions (pH 7.4) and
acid-adapted cells obtained by culturing under low pH conditions (6.8). Over the pHe range examined (6.0-7.6), the difference between
intracellular pH (pHi) and pHe increased with decreasing pHe. Acid-adapted cells were more resistant to acute changes in pHi than normal
cells, resulting in substantially larger gradients in these cells. Drug cell survival curves were performed at pHe values of 6.4, 6.8 and 7.4. The
cytotoxicity of chlorambucil, a weak acid, increased with decreasing pHe, and low pH-adapted cells were more sensitive than normal cells at
the same pHe. In contrast, for the weak base, mitoxantrone, cytotoxicity increased with pHe and was more pronounced in normal cells. As
predicted by the theory, the cytotoxicity of both drugs changed exponentially as a function of the pH gradient, regardless of cell type. For
mitoxantrone, the rate of such change in cytotoxicity with the gradient was approximately two times greater than for chlorambucil. This
difference is probably due to the presence of two equally ionizable crucial groups on mitoxantrone vs one group on chlorambucil. It is
concluded that the cellular pH gradient plays a major role in the pH-dependent modulation of cytotoxicity in these weak electrolytes. The data
obtained also suggest that a pronounced differential cytotoxicity may be expected in vivo in tumour vs normal tissue. In comparison with
normal cells at a pHe of 7.4 (a model of cells in normal tissues), acid-adapted cells at a pHe of 6.8 (a model of cells distal from supplying blood
vessels in tumours) were more sensitive to chlorambucil, with a dose-modifying factor of approximately 6, and were more resistant to
mitoxantrone by a factor of 14.
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As discussed recently (Gerweck and Seetharaman, 1996), the
cellular transmembrane pH gradient is significantly decreased, or
even reversed, in human solid tumours compared with the corre-
sponding normal tissue. While the intracellular pH (pHi) is similar
in both tissues (7.0-7.2 in normal and 7.1-7.3 in tumour tissue),
the extracellular pH (pHe) is, on average, 0.2 pH units higher in
normal tissues and 0.2-0.6 lower in tumours than pHi. This in vivo
difference in cellular pH gradients provides a rationale for the
selective intracellular accumulation of various lipophilic drugs,
which are weak electrolytes, in tumours or normal tissues.
In solution, such chemicals exhibit both a neutral and an ionized
form, and the balance ofthese forms is determined by the dissoci-
ation constant (pKa) of the drug and the pH of its solvent.
Assuming that only the non-ionized form enters the cell freely by
passive diffusion across the plasma membrane, the total steady-
state concentrations of the substance (including its charged and
uncharged forms) will differ in the intracellular and extracellular
compartments, if a transmembrane pH gradient exists. Weak acids
will concentrate preferentially in the basic compartment and weak
bases in the acidic compartment. The expected distribution ofsuch
drugs across the membrane at equilibrium can be derived theoreti-
cally in terms of pHe, pHi and pKa (see Materials and methods),
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and the equations clearly show that drug partitioning is strongly
dependent on the difference between pHe and pHi.
Although a number ofstudies have demonstrated pH-dependent
changes in the uptake, cytotoxicity or radiomodifying efficacy of
weak electrolytes, few have compared the data quantitatively with
the predictions of the pH partition theory. Examples include
studies of the chemotherapeutic drug, chlorambucil (Brophy and
Sladek, 1983; Mikkelsen et al, 1985), and the nitroimidazole
radiosensitizers (Dennis et al, 1985).
Cells adapted to prolonged growth at a decreased pHe maintain
a higher pHi over a wide range ofacutely modified pHe than their
unadapted counterparts (Chu and Dewey, 1988; Cook and Fox,
1988; Wahl et al, 1996). Therefore, a differential uptake (and cyto-
toxicity or radiomodifying efficacy) of weak electrolytes in cells
of these two types may be expected. Such comparative results
would be especially informative from the therapeutic point of
view, because typical intracellular-extracellular pH conditions
observed in vivo for tumour and normal cells may be simulated.
In the present study, the cytotoxicity of the alkylating agent,
chlorambucil (a weak acid), and of the anthracenedione antineo-
plastic, mitoxantrone (a weak base), was evaluated in normal and
low pH-adapted Chinese hamster ovary (CHO) cells. These drugs
were selected for consideration because their cellular uptake into
cells is known to occur by passive diffusion (e.g. Mikkelsen et al,
1985; Bums et al, 1987). Normal CHO cells grown in media at
pH 7.4 served as a model for cells in a normal tissue microenvi-
ronment, and acid-adapted cells, obtained by long-term culturing
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ofthe same CHO cells in media at a decreased pH (6.8), simulated
a population of cells adapted to a tumour microenvironment. The
toxic effects ofthe two chemotherapeutics were evaluated concur-
rently in both cell types at various pHe. The results were compared
with the predicted difference in drug accumulation, based on the
measured cellular membrane pH gradient and known from the
literature drug pKa values.
MATERIALS AND METHODS
Cell culture
Chinese hamster ovary cells were cultured and studied in Ham's
F-12 medium supplemented with 12% fetal bovine serum plus
antibiotics. The medium was buffered with 15 mM Hepes and
10 mm Epps, and the pH was adjusted with 1 N HCI or 1 N NaOH.
Cells were grown as subconfluent monolayers and were reseeded
twice a week. Normal cells were incubated at 37°C in medium
adjusted to pH 7.4, and acid-adapted cells to pH 6.8. During the 3-4
day interval between cell transfers, the pH of the media decreased
progressively by 0.2-0.3 pH units in both cell types. Although
initially more prolonged during culturing at low pH, the doubling
time was only slightly greater in acid-adapted cells overthe passage
range used (30-70) than in normal cells: 14-15 and 13-
14 h respectively. Experiments were performed on exponentially
growing cells. The cells were trypsinized, counted, centrifuged and
resuspended in fresh medium at a specific pH.
Measurement of intracellular pH
Intracellular pH was evaluated by the method originally developed
by Waddel and Butler (1959), which is based on the equilibrium
distribution of the weak acid, ['4C]DMO ([2-'4C]5,5-dimethyl-
2,4-oxazolidinedione) across the cell membrane. This technique
was developed further and used frequently elsewhere (e.g. Chu
and Dewey, 1988; Fellenz and Gerweck, 1988).
Briefly, cell suspensions (5-10 x 105 cells ml-') were labelled
concurrently with 3H20 and [14C]DMO or [14C]inulin. Twenty to
thirty minutes after the adjustment of pHe at 37°C, aliquots of
1.0 ml in 1.5-ml polypropylene microfuge tubes were centrifuged
through 0.2 ml ofsilicone oil into 0.06 ml of0.8 M perchloric acid.
Small aliquots of the superuatant were removed and counted by
liquid scintillation to determine the extracellular concentrations of
['4C]DMO, [14C]insulin and 3H20. The supernatants and part ofthe
oil were then aspirated, and 0.05-ml aliquots ofthe perchloric acid
cell extracts were removed for analysis using a needle inserted
through the remaining oil. Counts were corrected for background,
and pHi values were calculated as follows:
pHi = pKa + log {[C/C(1 + Ve/ V) - Ve/VI] (1)
X [lOpHe-pKa +I1-1},
where pKa is the dissociation constant of DMO (6.13 at 37°C), Ct
is the ['4C]DMO concentration in total cellular water in the cell
pellet, Ce is the ['4C]DMO concentration in extracellular water
(measured in the supernatant), Ve is the extracellular water in the
cell pellet, Vj is the intracellular water in the cell pellet. ['4C]inulin
was used as a marker of Ve and 3H20 as a marker oftotal water (V1)
in the pellet; V = Vt - V.
For both cell types (date not shown), Ve increased slightly, while
V was almost constant with decreasing pHe from 7.6 to 6.0. The
ratioVe/V, was 0.27-0.29 at pHe 7.6 and 0.38-0.40 at pHe 6.0. The
corresponding values of Ve/Vi were substituted into equation 1 to
calculate pHi at different pHe.
Chemotherapeutic treatments and determination of cell
surviving fraction
Chlorambucil (Sigma, St Louis, MO, USA) was freshly dissolved
in methanol at a concentration of 15-30 mg ml' and then appropri-
ately diluted with media. Aqueous solution of mitoxantrone,
2 mg ml' (Novantrone, Immunex Corporation, Seattle, WA, USA)
was also diluted in fresh media immediately before use. Drug toxi-
city was evaluated at pHe values of 7.4, 6.8 and 6.4 (± 0.05 pH
unit). Single cell suspensions (2 x 105 cells ml-') were prepared in
media at the proper pH, and variable drug doses in small volumes
were added to 1.0-ml aliquots of the cell suspension, yielding the
appropriate final drug concentration. Cells were then incubated for
90 min at 37°C with gentle continuous agitation.
After treatment, the cells were centrifuged, rinsed twice with
fresh medium and seeded in 25-cm2 plastic flasks to yield 50-200
colonies. Four to six flasks were used for each data point. Medium
at pH 7.4 was used for washing and cloning of normal cells, and
pH 6.8 medium was used for acid-adapted cells. After incubation,
the colonies were stained and counted. Cell survival was calcu-
lated as the ratio ofthe number ofcolonies divided by the number
ofcells plated in treatment vs control flasks. In the absence ofdrug
treatment, the plating efficiency was close to 100% independent of
the pHe and cell type. The drug enhancement ratio (ER) was calcu-
lated as the ratio of drug doses yielding a surviving fraction of
10% under the various experimental conditions. All experiments
were repeated 2-4 times.
Calculation of intracellular drug concentration
The observed changes in drug cytotoxicity as a function of pH
were compared with the predicted changes in the intracellular
(cytoplasmic) concentration of chlorambucil and mitoxantrone.
The prediction is based on the assumption that the cell membrane
is impermeable to the ionic form, and readily permeable to the
uncharged form of weak electrolytes; at equilibrium, the concen-
tration of the latter from becomes equal on both sides of the
membrane.
For chlorambucil, as for a weak acid with one ionizing group,
the intracellular/extracellular concentration ratio at equilibrium is
expected to be:
Ct/Ce = (1 + lOpHi-pKa)/(1 + lOpHe-pKa), (2)
where Cj and Ce are total (charged plus uncharged forms) intra-
cellular and extracellular drug concentrations respectively (e.g.
Roos and Boron, 1981). The pKa of the drug is approximately
5.8 at 37°C (Mikkelsen et al, 1985).
Mitoxantrone contains two symmetrical pairs ofbasic ionizable
groups, necessitating a modification of the derivation of the Ci/Ce
ratio. The pKa values of the different amino groups are approxi-
mately 5.99 and 8.13 (Duchateau, 1987). Assuming that a single
ionization renders the drug impermeable to membrane diffusion,
the two most readily ionizable groups (pKa of 8.13 for each) will
be the determinant of diffusion, and the fraction of neutral mole-
cules must be calculated as the probability that both these groups
are independently uncharged. In this case, the Ci/Ce ratio is derived
as follows:
CJ/C = [(1 + l0pKa-pHi)/(l + lOpKa-pHi))]2 (3)
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Figure 1 Relationship between pHe and pHi in normal (@) and acid-
adapted (0) CHO cells. Each point represents the mean of 11-12
measurements (± s.d.)
Note that this equation is significantly different from equation (2),
as its right side is squared.
RESULTS
The relationship between pHe and pHi for the two types of cells is
shown in Figure 1. The intracellular pH of acid-adapted cells was
relatively invariant over a wide range ofexracellular pH compared
with their normal counterparts. The pH curve ofacid-adapted cells
exhibited a plateau over the extracellular pH range of7.6-6.8, and
significant changes in pHi were apparent only when the pHe
decreased below 6.8. For normal cells, pHi decreased with
decreasing pHe, especially as the extracellular pH decreased
below 7.0. In general, the curve for acid-adapted cells was signifi-
cantly shifted to the left (by 0.6-0.7 pH units) and slightly up (by
approximately 0.1 pH unit) compared with normal cells. The
difference between pHi and pHe increased with decreasing pHe in
both cell types.
Extracellular pH values of6.4, 6.8 and 7.4 were selected for the
evaluation of drug cytotoxicity. These pHe values span the range
of naturally occurring or induced (e.g. by glucose, see Ashby,
1966; Thistlethwaite et al, 1987) interstitial pH conditions of
tumour and normal tissues in vivo. Additionally, this extracellular
pH range gave rise to a substantial (and importantly, different)
membrane pH gradient range in both normal and adapted cells.
Figure 2A shows the survival ofcells treated with the weak acid,
chlorambucil, at pHe 6.4 and 6.8. Both cell types were more sensi-
tive to killing at lower pHe; additionally, acid-adapted cells were
more chemosensitive than normal cells. The general shape of the
survival curves was similar for both normal and acid-adapted cells
at both pHe values. Cytotoxicity was more dependent on pHe
during treatment (a change in pHe from 6.8 to 6.4 sensitized both
cells with an ER of 2.2-2.9) than on the type of cells (the differ-
ence between cell types was in the range of 1.3-1.8).
The cytotoxic effects ofthe weakbase, mitoxantrone, at pHe 6.4
and 6.8 are shown in Figure 2B. The shape of the survival curves
4
Mitoxantrone (gg ml-1)
Figure 2 Cytotoxicity of chlorambucil (A) and mitoxantrone (B) in normal
(closed symbols) and acid-adapted (open symbols) CHO cells exposed to
the drugs for 1.5 h at pHe 6.8 (circles) or 6.4 (triangles). The data represent
the mean values (± s.e.) from two experiments with chlorambucil and three
experiments with mitoxantrone
was significantly different from that obtained forchlorambucil and
varied slightly with pHe. As expected, both types of cells were
more sensitive to mitoxantrone at higher pHe, and normal cells
were more sensitive than acid-adapted cells. Drug effectiveness
changed by a factor of 3.2-5.0 because of the difference in pHe
and by a factor of 1.2-1.5 as a result ofcellular pH adaptation.
Figure 3 shows the results ofthe cytotoxicity studies when both
cell types were treated in the medium in which they had been culti-
vated, i.e. normal cells at pHe 7.4 and low pH-adapted cells at 6.8.
Note that, under these conditions, cells ofboth types had approxi-
mately the same pHi (see Figure 1). Marked differences in cyto-
toxicity were observed: chlorambucil was substantially more toxic
in acid-adapted cells, with an ER of approximately 6.0; mitox-
antrone was 14 times more effective against normal cells.
The cytotoxicity of the drugs was also measured for both cell
lines at pHe 7.4 (data not shown). In all four experiments with
chlorambucil, acid-adapted cells were more chemosensitive than
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Figure 3 Cytotoxicity of chlorambucil (A) and mitoxantrone (B) for normal
cells at pHe 7.4 (U) and acid-adapted cells at pHe 6.8 (0). The data
represent the mean values (± s.e.) from two experiments with chlorambucil
and three experiments with mitoxantrone
normal cells, with an ER of 1.51 ± 0.19 (mean ± s.e.), as evaluated
at the 10% survival levels from full survival curves. In contrast,
low pH-adapted cells were 1.26 ± 0.08 times more resistant to
mitoxantrone than normal cells (mean ± s.e. from three experi-
ments).
Figure 4 summarizes the experimental data on the changes in
cytotoxicity as a function of pHe. Arbitrarily, all data were
normalized to the values for normal cells at pHe 6.8. For both
drugs, the observed changes in cell chemosensitivity agreed quali-
tatively with the expected changes in drug intracellular accumula-
tion. For the weak acid, chlorambucil, cytotoxicity was most
pronounced under acidic conditions. As the gradient between pHi
and pHe increased with decreasing pHe, an increasing proportion
ofthe drug was probably retained in the intracellular compartment.
For the weak base, mitoxantrone, the observed modification of
cytotoxicity as a function of pHe was the opposite, also as
Figure 4 Modification of the cytotoxicity of chlorambucil (A) and
mitoxantrone (B) by variation in pHe. Data points are the mean (± s.e.) of the
enhancement ratios from individual experiments. Closed symbols are for
normal cells, open symbols for acid-adapted cells. All data are normalized to
the values for normal cells at a pHe of 6.8
predicted. Both normal and low pH-adapted cells exhibited the
same trends. However, at any particular pHe, adapted cells were
more sensitive to chlorambucil and resistant to mitoxantrone prob-
ably owing to higher pHi. The pHe-related changes in the ER were
more pronounced for mitoxantrone than for chlorambucil.
The results presented in Figure 5 demonstrate directly the role
of the pH gradient in the cytotoxicity of the drugs. For each drug,
ignoring one circled point for normal cells (corresponding to a
pHe - pHi difference of - 0.46 at pHe of 6.4), the data for both
normal and low pH-adapted cells (closed and open symbols) fit a
common curve. The predicted changes in accumulation (based on
equations 2 and 3) are shown as small symbols and dashed lines.
The slopes of the observed and predicted curves are similar for
each drug. The curves for mitoxantrone are approximately twice as
steep as those for chlorambucil.
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Figure 5 The dependence of changes in cytotoxicity of chlorambucil (A) and
mitoxantrone (B) on cellular transmembrane pH gradient. Data points (squares,
closed for normal and open for low pH-adapted cells) are derived from the
results in Figures 1 and 4. For each drug, all data are fitted to a common curve,
ignoring one circled point for normal cells with a pH gradient of - 0.46
(corresponding to a pHe of 6.4). The corresponding theoretically predicted
absolute (not normalized) values of the Ci/Ce ratio are indicated by smaller
triangles and fitted to common curves (dashed lines), regardless of cell type
DISCUSSION
Normal and low pH-adapted CHO cells were used in this study.
The doubling times and plating efficiencies were essentially
identical in both cell types. However, the adapted cells exhibited
substantially larger gradients (pHi
- pHe) after acute changes in
extracellular pH. The relationship between the intracellular and
extracellular pH in normal and adapted cells was similar to that
obtained by Cook and Fox (1988) and Chu and Dewey (1988).
Wahl et al (1996) also reported a higher pHi in acid-adapted vs
normal CHO cells. However, in their study, the pH gradient was
generally larger, and there was no pHi stabilization over the
physiological pHe range in either cell type. The reason for this
difference is unknown but may relate to the different temperature,
serum or sodium bicarbonate concentrations or other technical
conditions under which pH was assessed. In all of these studies,
the pH gradient was assayed in trypsin-suspended cells.
Previous studies with non-low pH-adapted cells have shown an
enhanced toxicity and/or uptake of chlorambucil at low pHe
(Brophy and Sladek, 1983; Mikkelsen et al, 1985; Jahde et al,
1989; Skarsgard etal, 1992; Atema etal, 1993; Parkins et al, 1996)
and the opposite effects for mitoxantrone (Jahde et al, 1990;
Vukovic and Tannock, 1997). The present experimental results for
both normal and acid-adapted cells are consistent with these
observations. More importantly, they show that modification of
cytotoxicity occurs in accordance with the predicted changes in
intracellular drug concentration based on the transmembrane pH
gradient, regardless ofcell type. Thisprovides strong evidence that
the gradient is the major determinant ofpH-dependent changes in
drug uptake, assuming the cytotoxicity is proportional to the actual
cytoplasmic drug concentration. The pH partition hypothesis, in
particular, also explains the observed difference in chemosensi-
tivity between normal and low pH-adapted cells at the same pHe.
The only exception to the relationship between the predicted
and observed data was obtained in unadapted cells at a pHe of6.4
(circled data, Figure SA and B). The magnitude ofthis deviation is
greater than would be expected by assay imprecision for estima-
tion of pH values (less than ± 0.1 pH units), and the cause of this
difference is not obvious. It does not appear to be caused by an
extracellular pH effect at the membrane or by drug levels as, for
both drugs, the predicted modification oftoxicity was observed in
adapted cells at the same pHe. It seems important, however, that
the intracellular pH was substantially reduced at a pHe of6.4 only
in normal cells. This suggests that one or more steps in the intra-
cellular metabolism, toxicity or binding of the topoisomerase
inhibitor, mitoxantrone, and alkylating agent, chlorambucil, were
additionally influenced by decreased pHi.
For chlorambucil, a similar apparent discrepancy between
changes in cytotoxicity and predicted uptake has been obtained by
others in unadapted cells when pHi markedly changed with pHe.
Brophy and Sladek (1983) noted that the difference in toxicity at a
pHe of7.2 and 7.8 was more pronounced than predicted by theory.
Analysis ofthe data reported by Jahde et al (1989) and Atema et al
(1993) also shows that the modification of cytotoxicity by pHe
was larger than would be expected on the basis of their measure-
ments ofpHi. Additionally, the role of decreased pHi in the cyto-
toxicity of chlorambucil seems to be supported by the data of
Skarsgard et al (1995) for melphalan, a drug analogous to chlor-
ambucil but transported into cells by carrier-mediated systems.
They showed that the cytotoxicity of melphalan could be potenti-
ated by low pHe, which undoubtedly decreased pHi as well, with
no significant effect on drug uptake.
As seen in Figure 5, the change in toxicity over the wide pH
gradient range was much more pronounced for mitoxantrone than
forchlorambucil, and this can be explained on the basis ofdifferent
dissociation patterns ofthe molecules. As the pKa = 5.8 is substan-
tially lowerthan allpHe andpHi values forchlorambucil, itfollows
from equation 2 that log(Cq/Ce) is approximately equal to
(pHi - pHe). A similar approximation is also valid for equation 3,
because the pHe = 8.13 for each oftwo crucial protonating groups
of mitoxantrone is much larger than pHe and pHi; however,
because ofthe presence oftwo equally ionizable groups, log(C/Ce)
becomes 2(pHe - pHi), as was observed. This provides a clear
demonstration of the importance not only of the magnitude of the
pH gradient, but also ofthe particular features ofdrug dissociation.
On average, the extracellular pH is lower in tumours than
normal tissues (Wike-Hooley et al, 1984; Vaupel et al, 1989) and,
as recently pointed out by Gerweck and Seetharaman (1996), the
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extracellular pH of tumour tissue was found to be consistently
lower than in normal tissue when both tissues were assessed in the
same patient at the same time using the same electrode. However,
the intracellular pH of both tumour and normal tissue is approxi-
mately equal, even with a tendency for a slightly increased pHi in
tumours (Vaupel et al, 1989; Gerweck and Seetharaman, 1996).
Additionally, in animal tumour models, Helmlinger et al (1997)
have shown that a substantial decrease in pHe occurs with
increasing radial distance from supplying blood vessels. As a
consequence, the cellular transmembrane pH gradient is probably
most pronounced in those tumour regions that are most distal from
supplying vessels and least accessible to chemotherapeutics or
other blood-delivered tumour agents. These regions, therefore,
may be expected to exhibit the highest intracellular to extracellular
drug concentration ratio for lipophilic weak acids with appropriate
pKas (approximately 6.5 or lower, see Gerweck and Seetharaman,
1996). This microregional effect would be of therapeutic signifi-
cance, not only for cytotoxic drugs but also for substances
possessing therapeutic modifying properties. The extent to which
the effect of increased intracellular accumulation offsets the
decreased extracellular drug delivery deserves further investiga-
tion in vivo.
In summary, this study demonstrates a major role for the trans-
membrane pH gradient in modifying the cytotoxicity ofweak elec-
trolytes. Adaptation ofcells to an acid microenvironment results in
an increased intracellular pH and, therefore, an additional modula-
tion of cellular chemosensitivity. The use of weak acidic
chemotherapeutics represents a promising method for the prefer-
ential killing of tumour cells, including those located at increasing
distances from their supplying blood vessels.
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